•  74
    Doping in sport counts as a typical example of unfair behaviour and a good illustration of ethical problems produced by enhancement activities. However, there are some authors who argue that enhancement in sport is not intrinsically problematic but only so in those circumstances that make it dangerous for athletes or unfair to competitors, or which give rise to suspicion in the viewing public. In contrast to this, the author of the present article shows that enhancement activities are contradict…Read more
  •  26
    Objectives: Clinical trials in humans in Germany—as in many other countries—must be approved by local research ethics committees . The current study has been designed to document and evaluate decisions of chairpersons of RECs in the problematic field of non-therapeutic research with minors. The authors’ purpose was to examine whether non-therapeutic research was acceptable for chairpersons at all, and whether there was certainty on how to decide in research trials involving more than minimal ris…Read more
  •  20
    Is the commercialisation of human tissue and body material forbidden in the countries of the European Union?
    with Katharina Beier
    Journal of Medical Ethics 38 (6): 342-346. 2012.
    The human body and its parts are widely perceived as matters beyond commercial usage. This belief is codified in several national and European documents. This so-called ‘no-property rule’ is held to be the default position across the countries of the European Union. However, a closer look at the most pertinent national and European documents, and also current practices in the field, reveals a gradual model of commercialisation of human tissue. In particular, we will argue that the ban on commerc…Read more
  •  19
    Human Tissue Research. A European perspective on the ethical and legal challenges (edited book)
    with Nils Hoppe, Katharian Beier, and Claudia Wiesemann
    Oxford University Press. 2011.
    It will be of value to medics and social scientists, human tissue researchers, and policy makers who have an interest in ethical and legal issues of human tissue research.
  •  17
    Different concepts and models of information for family-relevant genetic findings: comparison and ethical analysis
    with Debora Frommeld
    Medicine, Health Care and Philosophy 18 (3): 393-408. 2015.
    Genetic predispositions often concern not only individual persons, but also other family members. Advances in the development of genetic tests lead to a growing number of genetic diagnoses in medical practice and to an increasing importance of genetic counseling. In the present article, a number of ethical foundations and preconditions for this issue are discussed. Four different models for the handling of genetic information are presented and analyzed including a discussion of practical implica…Read more
  •  15
    Normative Rahmenbedingungen der Rekrutierung und Nutzung extrahierter Zähne in Forschung und Lehre
    with Dominik Groß and Brigitte Utzig
    Ethik in der Medizin 28 (1): 21-31. 2016.
    ZusammenfassungJeder extrahierte Zahn ist primär Eigentum des betreffenden Patienten und unterliegt dessen autonomiebasiertem Selbstbestimmungsrecht. Diesem weitgehend unstrittigen Sachverhalt steht die praktische Notwendigkeit gegenüber, extrahierte Zähne für Forschung und Lehre bereitzustellen. So ist z. B. die Erprobung neuer Wurzelfüllmaterialien und -techniken ohne den Einsatz extrahierter Zähne ebenso wenig denkbar wie eine zahnbezogene praktische Ausbildung angehender Zahnärzte im Rahmen …Read more
  •  12
    Process of risk assessment by research ethics committees: foundations, shortcomings and open questions
    with Pranab Rudra
    Journal of Medical Ethics 47 (5): 343-349. 2021.
    Risks and burdens in the study participation, as well as an adequate risk-benefit balance, are key concepts for the evaluation of clinical studies by research ethics committees. An adequate assessment and continuous monitoring to ensure compliance of risks and burdens in clinical trials have long been described as a central task in research ethics. However, there is currently no uniform and solid theoretical approach to risk assessment by RECs. Regulatory standards of research ethics such as the…Read more
  •  9
    Nanomedicine–emerging or re-emerging ethical issues? A discussion of four ethical themes
    with Nikola Biller-Andorno
    Medicine, Health Care and Philosophy 10 (2): 173-184. 2007.
    Nanomedicine plays a prominent role among emerging technologies. The spectrum of potential applications is as broad as it is promising. It includes the use of nanoparticles and nanodevices for diagnostics, targeted drug delivery in the human body, the production of new therapeutic materials as well as nanorobots or nanoprotheses. Funding agencies are investing large sums in the development of this area, among them the European Commission, which has launched a large network for life-sciences rela…Read more
  •  7
    Save your favourite articles and useful searches
    with R. T. Meulen and N. Biller-Andorno
    Journal of Medical Ethics 33 (7). 2004.